NSE · VIVIMEDLAB
Vivimed Labs Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#4,538
of 5,004 stocks
🏆 New peak
▲ 291W
Peak #4,538 · 01 Oct 2026
Operating in Healthcare, Vivimed Labs Limited is seeing revenue contract sharply, generates a high return on equity, and has a widely-held ownership base, with promoters at just 8%.
Market Cap
9.02 Cr
P/E Ratio
—
P/B Ratio
—
ROE
83.30%
ROCE
-56.02%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 | Q1 2025-26 |
|---|---|---|---|---|
| Revenue | 12.00 Cr | 15.99 Cr | 20.61 Cr | 21.39 Cr |
| Net Profit | -146.04 Cr | -16.55 Cr | -7.30 Cr | -5.49 Cr |
| EPS | -17.74 | -0.88 | -0.88 | -0.66 |
| Operating Profit | -144.95 Cr | -15.55 Cr | -5.65 Cr | -4.92 Cr |
Shareholding pattern
Promoter
7.57%
Public
92.43%
Mutual fund holdings
Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 27 Dec 2024 | Other | Annual General Meeting |
| 07 Nov 2023 | Other | Annual General Meeting |
| 21 Mar 2023 | Other | Annual General Meeting |
| 10 Feb 2023 | Other | Annual General Meeting |
| 23 Dec 2020 | Other | Annual General Meeting |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.